Efg Asset Management (North America) Corp. Blueprint Medicines Corp Transaction History

Efg Asset Management (North America) Corp.

$705 Million
Q4 2024

A detailed history of Efg Asset Management (North America) Corp. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 74,300 shares of BPMC stock, worth $6.99 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

74,300

Previous 33,689 120.55%

Holding current value

$6.99 Million

Previous $3.11 Million 108.09%

% of portfolio

0.92%

Previous 0.53%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$82.48 - $101.39 $3.35 Million - $4.12 Million	40,611 Added 120.55%	74,300 $6.48 Million
Q3 2024 Nov 12, 2024	BUY	$84.1 - $120.5 $488,200 - $699,502	5,805 Added 20.82%	33,689 $3.11 Million
Q2 2024 Jul 25, 2024	BUY	$85.18 - $108.78 $11,243 - $14,358	132 Added 0.48%	27,884 $3.01 Million
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $114,584 - $156,271	1,566 Added 5.98%	27,752 $2.63 Million
Q4 2023 Feb 08, 2024	SELL	$43.96 - $92.84 $28,617 - $60,438	-651 Reduced 2.43%	26,186 $2.42 Million
Q3 2023 Nov 02, 2023	SELL	$46.9 - $66.0 $2.97 Million - $4.18 Million	-63,287 Reduced 70.22%	26,837 $1.35 Million
Q2 2023 Jul 28, 2023	SELL	$42.2 - $66.37 $844,717 - $1.33 Million	-20,017 Reduced 18.17%	90,124 $5.7 Million
Q1 2023 Apr 27, 2023	SELL	$37.97 - $50.0 $27,034 - $35,600	-712 Reduced 0.64%	110,141 $4.96 Million
Q4 2022 Feb 03, 2023	SELL	$41.06 - $66.48 $170,029 - $275,293	-4,141 Reduced 3.6%	110,853 $4.86 Million
Q3 2022 Oct 28, 2022	SELL	$49.93 - $77.7 $771,917 - $1.2 Million	-15,460 Reduced 11.85%	114,994 $7.58 Million
Q2 2022 Aug 04, 2022	SELL	$45.23 - $70.15 $282,099 - $437,525	-6,237 Reduced 4.56%	130,454 $6.59 Million
Q1 2022 Apr 26, 2022	BUY	$54.1 - $110.08 $1.3 Million - $2.64 Million	23,976 Added 21.27%	136,691 $8.73 Million
Q4 2021 Feb 18, 2022	BUY	$94.25 - $115.99 $10.6 Million - $13.1 Million	112,715 New	112,715 $12.1 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.62B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account

Efg Asset Management (North America) Corp. Blueprint Medicines Corp Transaction History